Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Triamcinolone diacetate
Drug ID BADD_D02273
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code Not Available
DrugBank ID Not Available
KEGG ID D00984
MeSH ID C030262
PubChem ID 6216
TTD Drug ID Not Available
NDC Product Code 52128-171; 46439-8766; 49452-7910
UNII A73MM2Q32P
Synonyms triamcinolone diacetate | Polcartolone | Polcortolon
Chemical Information
Molecular Formula C25H31FO8
CAS Registry Number 67-78-7
SMILES CC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)OC(=O)C)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Osteoporosis14.04.04.002; 15.02.03.002--
Pancreatitis07.18.01.001--
Papilloedema06.09.02.002; 17.07.02.004; 24.03.07.001--
Paraesthesia17.02.06.005; 23.03.03.094--
Paraparesis17.01.04.006---
Paraplegia17.01.04.007---
Pathological fracture12.04.02.006; 15.08.02.008; 16.32.03.007---
Peptic ulcer07.04.07.001---
Personality change17.02.05.019; 19.05.01.006--
Petechiae01.01.03.002; 23.06.01.003; 24.07.06.004---
Pulmonary oedema02.05.02.003; 22.01.03.003--
Secondary adrenocortical insufficiency05.03.04.012; 14.11.01.014---
Seizure17.12.03.001--
Sensory disturbance17.02.07.006---
Skin atrophy23.01.05.001--
Skin exfoliation23.03.07.003---
Skin hyperpigmentation23.05.01.003--
Skin hypopigmentation23.05.02.003--
Spermatozoa abnormal13.20.04.009---
Spinal fracture12.04.04.002; 15.08.05.001--
Syncope02.11.04.015; 17.02.04.008; 24.06.02.012--
Tachycardia02.03.02.007---
Tendon rupture12.01.07.003; 15.07.01.008---
Thrombophlebitis24.01.02.001---
Vasculitis10.02.02.006; 24.12.04.027--
Vertigo04.04.01.003; 17.02.12.002--
Weight increased13.15.01.006--
Oesophagitis ulcerative07.04.05.003---
Growth retardation05.03.02.007; 14.03.02.031; 15.03.05.016--
Affect lability19.04.01.001---
The 3th Page    First    Pre   3 4    Next   Last    Total 4 Pages